Dosage Form: FOR ANIMAL USE ONLY
ChlorMax®
50
Chlortetracycline
Type A Medicated Article
Antibacterial
Active drug ingredient
Chlortetracycline (as hydrochloride) ....................................................................................... 50 g/lb
Inert ingredients
Roughage products, silicon dioxide, mineral oil
For use in manufacturing medicated feed only
| Indications for use | Chlortetracycline mg / lb body wt / day |
|---|---|
| Cattle | |
| Calves (up to 250 lbs, in milk replacers or starter feeds): For an increased rate of weight gain and improved feed efficiency. | 0.1 |
| Beef cattle (over 700 lbs): Control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline. Withdraw 48 hours prior to slaughter. | 0.5 |
| Calves, beef and non-lactating dairy cattle: Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. Treat for not more than 5 days. Withdraw 24 hours prior to slaughter. | 10 |
| Swine | |
| Control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracycline. Treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. (Note: This drug level is equivalent to 400 grams per ton, depending on feed consumption and body weight). Feed for not more than 14 days. | 10 |
| Turkeys | |
| Control of complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis) susceptible to chlortetracycline. Feed continuously for 7 to 14 days. | 25 |
| Indications for use | mg / head / day |
| Cattle | |
| Calves (250 - 400 lbs): For an increased rate of weight gain and improved feed efficiency. | 25 - 70 |
| Growing cattle (over 400 lbs): For an increased rate of weight gain, improved feed efficiency and reduction of liver condemnation due to liver abscesses. | 70 |
| Beef cattle: For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline. Withdraw 48 hours prior to slaughter. | 350 |
| Beef cattle (under 700 lbs): Control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline. Withdraw 48 hours prior to slaughter. | 350 |
| Sheep | |
| Breeding sheep: Reducing the incidence of (vibrionic) abortion caused by Campylobacter fetus infection susceptible to chlortetracycline. | 80 |
| Indications for use | In complete feed Chlortetracycline g / ton |
| Chickens | |
| For an increased rate of weight gain and improved feed efficiency. | 10 - 50 |
| Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline. Feed continuously for 7 to 14 days. | 100 - 200 |
| Control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli susceptible to chlortetracycline. Feed continuously for 7 to 14 days. | 200 - 400 |
| Reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline. Feed for 5 days. Withdraw 24 hours prior to slaughter. | 500 |
| Turkeys | |
| Growing turkeys: For an increased rate of weight gain and improved feed efficiency. | 10 - 50 |
| Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline. Feed continuously for 7 to 14 days. | 200 |
| Control of hexamitiasis caused by Hexamita meleagridis susceptible to chlortetracycline. Feed continuously for 7 to 14 days. | 400 |
| Turkey poults not over 4 weeks of age: Reduction of mortality due to paratyphoid caused by Salmonella typhimurium susceptible to chlortetracycline. | 400 |
| Swine | |
| Growing swine: For an increased rate of weight gain and improved feed efficiency. | 10 - 50 |
| Reducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci susceptible to chlortetracycline. | 50 - 100 |
| Breeding swine: Control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline. Feed continuously for not more than 14 days. | 400 |
| Sheep | |
| Growing sheep: For an increased rate of weight gain and improved feed efficiency. | 20 - 50 |
Mixing directions
For use in manufacture of complete feeds, mix thoroughly as follows:
| Chlortetracycline, g/ton | ChlorMax 50, lb/ton |
|---|---|
| 10 - 50 | 0.2 - 1 |
| 20 - 50 | 0.4 - 1 |
| 50 - 100 | 1 - 2 |
| 100 - 200 | 2 - 4 |
| 200 - 400 | 4 - 8 |
| 500 | 10 |
For use in manufacture of feed supplements to be fed at a rate of 1 lb per head per day, mix thoroughly as follows:
| mg/lb body wt/day | If animal wt = 1000 lbs | ChlorMax 50 lb/ton supplement |
|---|---|---|
| 0.5 | 500 mg | 20 |
| 5.0 | 5,000 mg | 200 |
Caution
For control and treatment of diseases caused by organisms susceptible to chlortetracycline as indicated. Observe the limitations of use and withdrawal periods as indicated.
Warning
Do not feed to chickens or turkeys producing eggs for human consumption.
A withdrawal period has not been established for this product in preruminating calves.
Do not use in calves to be processed for veal.
Storage
Keep container tightly closed to prevent contamination or moisture pick-up.
For Use in Dry Feeds Only.
Not for Use in Liquid Medicated Feeds.
Restricted Drug (California) - Use only as directed. Not for human use.
NADA 46-699, Approved by FDA
Marketed by
Alpharma, LLC
Bridgewater, New Jersey 08807
Net wt 50 LB (22.68 kg)
Trademarks
registered by
Alpharma, LLC
700302 1006
PRINCIPAL DISPLAY PANEL - 22.68 LABEL
ChlorMax®
50
ALPHARMA
Chlortetracycline
Type A Medicated Article
Antibacterial
See mixing directions, claims, cautions
and warnings on back
Net wt 50 LB (22.68 kg)
ALPHARMA®
| ChlorMax 50 chlortetracycline granule | ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| Marketing Information | |||
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| NADA | NADA046699 | 01/02/2009 | |
| Labeler - Alpharma, LLC. (070954094) |
No comments:
Post a Comment